Jill Drachenberg

Jill Drachenberg is a healthcare and business journalist based in Atlanta. Contact her on LinkedIn.

Regeneron, Akouos and Mass Eye and Ear are testing therapies that can reverse genetic protein deficiency to restore hearing, with promising early results.
Halia Therapeutics, NodThera and Gain Therapeutics target neuroinflammatory processes in hopes of modifying the course of Parkinson’s progression.